U.S. markets close in 4 hours 35 minutes
  • S&P 500

    3,777.03
    -6.25 (-0.17%)
     
  • Dow 30

    30,197.01
    -76.86 (-0.25%)
     
  • Nasdaq

    11,159.18
    +10.54 (+0.09%)
     
  • Russell 2000

    1,756.20
    -6.49 (-0.37%)
     
  • Crude Oil

    88.53
    +0.77 (+0.88%)
     
  • Gold

    1,720.30
    -0.50 (-0.03%)
     
  • Silver

    20.55
    +0.01 (+0.03%)
     
  • EUR/USD

    0.9830
    -0.0054 (-0.55%)
     
  • 10-Yr Bond

    3.8160
    +0.0570 (+1.52%)
     
  • GBP/USD

    1.1178
    -0.0144 (-1.27%)
     
  • USD/JPY

    144.8140
    +0.2040 (+0.14%)
     
  • BTC-USD

    20,092.05
    +169.42 (+0.85%)
     
  • CMC Crypto 200

    457.19
    -5.94 (-1.28%)
     
  • FTSE 100

    6,999.18
    -53.44 (-0.76%)
     
  • Nikkei 225

    27,311.30
    +190.80 (+0.70%)
     

Radius Health to Release First Quarter 2022 Financial Results, Host Conference Call and Live Webcast on Thursday, May 5, 2022

·1 min read
Radius Health Inc.
Radius Health Inc.

BOSTON, April 25, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS) announced today that it will release its first quarter 2022 financial results on Thursday, May 5, 2022. The Company will host a conference call and live audio webcast at 8:30 a.m. ET to discuss the results and provide a business update.

Conference Call Information:
Domestic Dial-In Number: 1 (866) 323-7965
International Dial-In Number: 1 (346) 406-0961
Conference ID: 5844208
Webcast Link: https://edge.media-server.com/mmc/p/nmcknbsv

A replay of the conference call will be available on May 5th at 11:30 a.m. ET. A live audio webcast of the call will be archived on the Company's website for 12 months. To access the replay, dial (855) 859-2056 or (404) 537-3406 for International, using conference ID number 5844208. The live audio webcast of the call can be accessed from the Investors section of the Company’s website, https://ir.radiuspharm.com/events-and-presentations. The full text of the announcement and financial results will also be available on the Company’s website.

About Radius
Radius Health is a global biopharmaceutical company focused on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. Our team works collaboratively and relentlessly to advance our therapies; all with the goal of improving the lives of patients, their families, and their caregivers. The Radius portfolio consists of commercial and clinical development assets, including early to late-stage drug candidates. Find out more at www.radiuspharm.com.

Investor & Media Relations Contact:
Ethan Holdaway
Email: investor-relations@radiuspharm.com
Phone: (617) 583-2017